Vimarsana
Biggest News Aggregation in the World

Upper Limit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Upper Limit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Upper Limit Today - Breaking & Trending Today

NHL Announces 2024-25 Salary Cap Range - Bleacher Nation - Vimarsana News

NHL Announces 2024-25 Salary Cap Range - Bleacher Nation

The Blackhawks still need to spend to the get to the NHL's salary floor for the coming season.

Travere Therapeutics Reports First Quarter 2024 Financial Results - Vimarsana News

Travere Therapeutics Reports First Quarter 2024 Financial Results

FDA grants Priority Review for sNDA to convert FILSPARI® from accelerated approval to full approval for the treatment of IgAN in the U.S.; PDUFA target action date of September 5, 2024 Received 511...

Komatsu : Announcement Concerning Revision of Performance-Linked Stock-Based Remuneration System - Vimarsana News

Komatsu : Announcement Concerning Revision of Performance-Linked Stock-Based Remuneration System

Announcement Concerning Revision of Performance-Linked Stock-Based Remuneration System Apr. 26, 2024 Komatsu Ltd. hereby...

Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy - Vimarsana News

Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

First non-immunosuppressive therapy for the treatment of IgA nephropathy approved in Europe Conditional marketing authorization is based on statistically significant and clinically meaningful...

Travere Therapeutics to Present Abstracts on FILSPARI® (sparsentan) in IgA Nephropathy at World Congress of Nephrology and the American Nephrology Nurses Association - Vimarsana News

Travere Therapeutics to Present Abstracts on FILSPARI® (sparsentan) in IgA Nephropathy at World Congress of Nephrology and the American Nephrology Nurses Association

Upcoming data presentations underscore the potential for FILSPARI to become a foundational treatment for IgAN and Travere’s leadership and commitment to innovation in rare kidney disease SAN DIEGO,...